Roivant Sciences (ROIV) EBITDA (2021 - 2026)
Roivant Sciences' EBITDA was -$365.39 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$283.82 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) EBITDA (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Roivant Sciences' EBITDA was -$593.29 million through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$511.72 million.
- In earlier fiscal years, EBITDA was -$989.22 million in FY2025, $4.52 billion in FY2024, -$887.91 million in FY2023 and -$1.35 billion in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly EBITDA since fiscal Q3 2023.
- Per Business Quant data, ROIV's EBITDA in the three fiscal quarters before Q1 2027 was $415.88 million (Q4 2026), -$338.46 million (Q3 2026) and -$305.31 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Roivant Sciences | 25.19 Bn | 8.14 Bn | 1.16 Mn | -365.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -365.39 Mn |
| Mar 31, 2026 | 415.88 Mn |
| Dec 31, 2025 | -338.46 Mn |
| Sep 30, 2025 | -305.31 Mn |
| Jun 30, 2025 | -283.82 Mn |
| Mar 31, 2025 | -283.54 Mn |
| Dec 31, 2024 | -271.46 Mn |
| Sep 30, 2024 | -336.87 Mn |
| Jun 30, 2024 | -97.35 Mn |
| Mar 31, 2024 | -201.61 Mn |
| Dec 31, 2023 | 5.13 Bn |
| Sep 30, 2023 | -208.30 Mn |
| Jun 30, 2023 | -270.57 Mn |
| Mar 31, 2023 | 40.34 Mn |
| Dec 31, 2022 | -372.93 Mn |
| Sep 30, 2022 | -275.69 Mn |
| Jun 30, 2022 | -279.63 Mn |
| Mar 31, 2022 | -265.10 Mn |
| Dec 31, 2021 | -244.65 Mn |
API Access
Roivant Sciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();